第五节:蛋白质降解剂
Kiran Palyada1, Renee Hukkanen2, Stephanie Leuenroth-Quinn3
1Pfizer Inc., La Jolla, California, USA.
Toxicologic pathology
|December 11, 2024
概括
向蛋白质降解 (TPD) 提供了一种新方法,通过利用细胞的自然降解途径,为以前无法降解的蛋白质开发药物. 这次会议探讨了TPD的挑战,毒性和发展考虑.
科学领域:
- 药物开发 药物开发
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 这是一个很棒的节目,这是一个很棒的节目.
- 没有药物可用的无毒药.
- 蛋白质组在药物发现中提出了重大挑战.
- 向蛋白质降解 (TPD) 已成为解决这一挑战的有希望的治疗方式.
- TPD利用细胞内源性无素-蛋白酶体系统进行向的蛋白质清除.
研究的目的:
- 探索利用蛋白质降解剂作为新型治疗剂的挑战和前景.
- 讨论与TPD相关的目标和目标外毒性评估.
- 为开发和评估降解分子的安全性提出独特的考虑.
主要方法:
- 审查当前的TPD策略及其在药物开发中的应用.
- 通过IQ财团工作组调查分析目标和目标之外的毒性.
- 降解分子独特的吸收,分布,新陈代谢和分泌 (ADME) 特性.
- 讨论如何使用转基因模型来评估血毒性.
- 一个案例研究说明了剂量限制性血小板缺血的降低风险.
- 包括对TPD相关毒性的监管视角.
主要成果:
- TPD的模式正在从学术界转移到工业界,提供新的治疗途径.
- 降解分子的特定ADME特性影响药物开发和非临床安全.
- 血毒性,特别是血小板缺血,是一个关键的安全问题,需要仔细评估.
- 转基因模型和案例研究为管理TPD相关毒性提供了宝贵的见解.
结论:
- 蛋白质降解剂在向以前无法降解的蛋白质方面取得了重大进展.
- 解决ADME独特的特性和潜在的毒性,如血液毒性,对于成功开发TPD至关重要.
- 包括监管考虑在内的多学科方法对于推进TPD疗法至关重要.
相关概念视频
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Proteins: From Genes to Degradation
3.5K
3.5K
Amino Acid Catabolism
1
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1
Regulated Protein Degradation
2.5K
2.5K
The Proteasome Structure
697
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
697
Protein Digestion
102.6K
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
102.6K


